Compare InMode Ltd (INMD) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
InMode Ltd vs BIO-TECHNE Corp — how do they compare? InMode Ltd trades at $15.38 (market cap $882.90M), while BIO-TECHNE Corp trades at $71.63 (market cap $11.16B). The key difference: BIO-TECHNE Corp is far larger — about 12.6× InMode Ltd's market cap, and BIO-TECHNE Corp pays a 0.45% dividend while InMode Ltd pays none. Which is the better fit depends on your goals.
| INMD | TECH | |
|---|---|---|
Market Cap | $882.90M | $11.16B |
Sector | Technology | Health |
52-Week High | $16.62 | $72.12 |
52-Week Low | $12.76 | $43.31 |
Enterprise Value | $350.57M | $11.24B |
Dividend Yield | — | 0.45% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About InMode Ltd
InMode provides innovative medical technologies for minimally invasive surgical procedures. Its platforms use radiofrequency (RF) energy for aesthetic treatments like body contouring and skin tightening.
Read more on INMD →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
